• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童致残性全硬化性硬斑病——罕见病例及管理挑战

Disabling pansclerotic morphea of childhood--unusual case and management challenges.

作者信息

Forsea Ana-Maria, Cretu Aura-Nicoleta, Ionescu Ruxandra, Giurcaneanu Calin

机构信息

Carol Davila University of Medicine and Pharmacy, Department of Oncologic Dermatology and Allergology, Elias University Emergency Hospital, Bucharest.

出版信息

J Med Life. 2008 Jul-Sep;1(3):348-54.

PMID:20108512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5654307/
Abstract

Morphea, also known as localized scleroderma is a chronic disease of unknown etiology, characterized by fibrous deposition and obliteration of vessels in the skin. This disease has a wide clinical spectrum, ranging from mild hyperpigmented plaques to severe, invalidating generalized and pansclerotic forms. Disabling pansclerotic morphea of childhood is a rare and debilitating variant of localized scleroderma, characterized by a rapid progression of deep cutaneous fibrosis that involves the dermis and the subcutaneous adipose tissue but also fascia, muscles, and bone. Contractures and musculoskeletal atrophy develop and the disease has an invalidating and even fatal course. We present an unusual case of severe morphea in a 19-year-old girl, with a polymorphous clinical picture consisting of plaques, linear and pansclerotic, circumferential lesions, with symmetric, invalidating involvement of all limbs and explosive evolution with centripetal progression. This case emphasizes the unpredictable character of morphea evolution, the possible severe prognosis and the therapeutic challenges raised by the generalized, disabling forms of this disease.

摘要

硬斑病,也称为局限性硬皮病,是一种病因不明的慢性疾病,其特征是皮肤中纤维沉积和血管闭塞。这种疾病临床谱广泛,从轻度色素沉着斑到严重的、导致残疾的全身性和泛硬化型。儿童致残性泛硬化性硬斑病是局限性硬皮病的一种罕见且使人衰弱的变体,其特征是深部皮肤纤维化迅速进展,累及真皮、皮下脂肪组织,还包括筋膜、肌肉和骨骼。挛缩和肌肉骨骼萎缩出现,疾病呈致残甚至致命病程。我们报告一例19岁女孩的严重硬斑病罕见病例,其临床表现多样,包括斑块、线状和泛硬化性、环形病变,四肢均对称受累并致残,呈向心性进展的爆发性演变。该病例强调了硬斑病演变的不可预测性、可能的严重预后以及这种疾病全身性、致残性形式所带来的治疗挑战。

相似文献

1
Disabling pansclerotic morphea of childhood--unusual case and management challenges.儿童致残性全硬化性硬斑病——罕见病例及管理挑战
J Med Life. 2008 Jul-Sep;1(3):348-54.
2
Disabling pansclerotic morphoea of childhood.儿童致残性全硬化性硬斑病
BMJ Case Rep. 2018 Feb 17;2018:bcr-2017-222132. doi: 10.1136/bcr-2017-222132.
3
Disabling pansclerotic morphea: clinical presentation in two adults.致残性全硬化性硬斑病:两名成人的临床表现
J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S115-9. doi: 10.1016/j.jaad.2004.10.881.
4
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.儿童致残性泛发性硬斑病的诊断和治疗挑战:基于病例的回顾。
Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5.
5
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.波生坦治疗儿童致残性全硬化性硬斑病中难治性皮肤溃疡的疗效。
J Rheumatol. 2006 Dec;33(12):2538-40.
6
[Incapacitating pansclerotic morphea in childhood].[儿童致残性全硬化性硬斑病]
Med Cutan Ibero Lat Am. 1981;9(5):377-82.
7
[Morphea or juvenile localised scleroderma: Case report].[硬斑病或青少年局限性硬皮病:病例报告]
Rev Chil Pediatr. 2016 Jul-Aug;87(4):279-83. doi: 10.1016/j.rchipe.2016.01.013. Epub 2016 Mar 12.
8
[Severe course of a mutilating pansclerotic circumscribed scleroderma in childhood. Clinical aspects and therapy].[儿童致残性泛硬化性局限性硬皮病的严重病程。临床特点及治疗]
Hautarzt. 1999 Feb;50(2):131-5. doi: 10.1007/s001050050877.
9
Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution.病例研究:深部硬斑病需要进行定期随访以确定是否发生系统性病变。
Skinmed. 2005 May-Jun;4(3):188-90. doi: 10.1111/j.1540-9740.2005.03592.x.
10
Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.儿童致残性全硬化性硬斑病与低丙种球蛋白血症:一种奇特的关联。
Rheumatol Int. 2002 Jan;21(4):158-60. doi: 10.1007/s00296-001-0150-2.

引用本文的文献

1
Variant and Response to Ruxolitinib in an Autoinflammatory Syndrome.自身炎症性疾病中 Ruxolitinib 的变异体和反应。
N Engl J Med. 2023 Jun 15;388(24):2241-2252. doi: 10.1056/NEJMoa2202318. Epub 2023 May 31.
2
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.儿童致残性泛发性硬斑病的诊断和治疗挑战:基于病例的回顾。
Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5.
3
Disabling pansclerotic morphoea of childhood.儿童致残性全硬化性硬斑病

本文引用的文献

1
Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.儿童致残性全硬化性硬斑病存在皮肤慢性溃疡和鳞状细胞癌的高风险。
Int J Low Extrem Wounds. 2007 Dec;6(4):291-8. doi: 10.1177/1534734607308731.
2
Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.自分泌转化生长因子-β信号在系统性硬化症发病机制中的作用
J Dermatol Sci. 2008 Feb;49(2):103-13. doi: 10.1016/j.jdermsci.2007.05.014. Epub 2007 Jul 12.
3
Deep morphea.深部硬斑病
BMJ Case Rep. 2018 Feb 17;2018:bcr-2017-222132. doi: 10.1136/bcr-2017-222132.
4
Phototherapy in Scleroderma.硬皮病中的光疗
Dermatol Ther (Heidelb). 2016 Dec;6(4):519-553. doi: 10.1007/s13555-016-0136-3. Epub 2016 Aug 12.
5
Adult-onset unilateral disabling pansclerotic morphea.成人起病的单侧致残性全硬化性硬斑病。
Indian J Dermatol. 2014 May;59(3):316. doi: 10.4103/0019-5154.131459.
Semin Cutan Med Surg. 2007 Jun;26(2):90-5. doi: 10.1016/j.sder.2007.02.005.
4
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.波生坦治疗儿童致残性全硬化性硬斑病中难治性皮肤溃疡的疗效。
J Rheumatol. 2006 Dec;33(12):2538-40.
5
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.磷酸二酯酶-5抑制通过降低髓源性抑制细胞功能增强内源性抗肿瘤免疫力。
J Exp Med. 2006 Nov 27;203(12):2691-702. doi: 10.1084/jem.20061104. Epub 2006 Nov 13.
6
Phototherapy: a promising treatment option for skin sclerosis in scleroderma?光疗:系统性硬化症皮肤硬化的一种有前景的治疗选择?
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii52-iii54. doi: 10.1093/rheumatology/kel293.
7
Systemic and localized scleroderma.系统性和局限性硬皮病。
Clin Dermatol. 2006 Sep-Oct;24(5):374-92. doi: 10.1016/j.clindermatol.2006.07.004.
8
Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases.儿童泛发性硬斑病的治疗:病例报告及日本病例文献综述
Pediatr Int. 2006 Jun;48(3):342-5. doi: 10.1111/j.1442-200X.2006.02218.x.
9
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.青少年局限性硬皮病:750例儿童的临床和流行病学特征。一项国际研究。
Rheumatology (Oxford). 2006 May;45(5):614-20. doi: 10.1093/rheumatology/kei251. Epub 2005 Dec 20.
10
New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.系统性硬化症的新治疗策略——文献的批判性分析
Clin Dev Immunol. 2005 Sep;12(3):165-73. doi: 10.1080/17402520500233437.